New patent for the drug Esperion Theraps NEXLETOL – DrugPatentWatch
Annual Drug Patent Expiration for NEXLETOL
Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from a single supplier. There are six patents protecting this drug.
NEXLETOL drug price trends.
This drug has twenty patent family members in thirteen countries.
The generic ingredient in NEXLETOL is bempedoic acid. One registered supplier for this compound. Additional details are available on the bempedoic acid profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Esperion Theraps NEXLETOL